Industry
View all stories with this category.
-
BusinessLandmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
BusinessBuilding resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
ResearchGenentech antibiotic quells resistance
Modified arylomycin combines high potency with new mechanism of action
-
BusinessEurope opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
FeatureReaching a milestone
The decade-long process to register all chemicals used in Europe has concluded. Nina Notman takes stock of progress and looks to the next steps for chemical legislation in the region
-
BusinessUS court overturns plant safety rule delay
Appeal finds Trump’s postponement of the 2017 Chemical Disaster Rule was unlawful
-
NewsChemical reaction database in danger of closing down
Chemical Safety Library containing information on hazardous reactions is seeking a partner to help it stay afloat
-
OpinionFeeding the confusion
When it comes to working out what foods do to our bodies, mostly we just don’t know
-
NewsAccidents at cannabis cultivation facilities worry industry chemists
Incidents at marijuana growing facilities have caught the attention of the American Chemical Society, and its cannabis chemistry subdivision
-
OpinionBehind enemy lines
When trade war breaks out, globalised industries ship out to dodge tariffs
